April 19, 2023
The National Cerebral and Cardiovascular Center (NCVC) of Japan has launched a crowdfunding campaign for its ongoing clinical trial for tenecteplase, a fibrinolytic drug currently unapproved in the country. The move is aimed at securing funds to continue the researcher-led...read more